Circulating Cell-Free DNA as a potential Diagnostic Tool in Pancreatic Cancer: A Comparative Analysis
Liquid biopsies enable non-invasive tumor material sampling in patients with pancreatic adenocarcinoma (PDAC). Genetic information, especially alterations in circulating free DNA (cfDNA) levels, might help to predict poorer tumor differentiation, disease progression and might be used as treatment efficacy evaluator. However, the data on this topic is insufficient.
Authors
- Giedrius Barauskas (ORCID: https://orcid.org/0000-0002-4321-7280)
- Aldona Jasukaitienė (ORCID: https://orcid.org/0000-0002-4606-1963)
- Rita Kupčinskaitė-Noreikienė (ORCID: https://orcid.org/0000-0003-0958-5327)
- Ingrida Grabauskytė (ORCID: https://orcid.org/0000-0001-6117-6307)
- Vakare Gruodyte
- Romualdas Riauka
- Povilas Ignatavičius
- Antanas Gulbinas
Institutions
- Lithuanian University of Health Sciences (LT)
Publication Details
- Journal
- Lithuanian University of Health Sciences
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1159/000547870/935757/circulating-cell-free-dna-as-a-potential?redirectedfrom=fulltext
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00